Page last updated: 2024-08-16

mitomycin and 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one

mitomycin has been researched along with 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, C; Chen, CC; Chen, J; Huang, CP; Liu, G; Messing, E; Yeh, S; Zhang, Y	1

Other Studies

1 other study(ies) available for mitomycin and 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one

Article	Year
ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals. Journal of experimental & clinical cancer research : CR, 2019, Jun-24, Volume: 38, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Doxorubicin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; NF-kappa B; Receptors, Androgen; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays	2019

Article

Year

ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals.

Journal of experimental & clinical cancer research : CR, 2019, Jun-24, Volume: 38, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Doxorubicin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; NF-kappa B; Receptors, Androgen; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2019